Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

FDA Widens Cyclosporiasis Outbreak Investigation to Nine States Amid Taco Bell Lettuce Link

Cyclosporiasis is an intestinal illness caused by the parasite Cyclospora cayetanensis, typically contracted through consumption of contaminated food or water. The infection commonly causes watery diarrhea, loss of appetite, weight loss, cramping, bloating, nausea and fatigue, with symptoms sometimes persisting for weeks if left …

Nitish Kishor | 25 July 2026

Eli Lilly Bets on Preventive Medicine and Silicon Valley Playbook to Reinvent Pharma

Eli Lilly (NYSE:LLY) has become the world's most valuable drugmaker and the first pharmaceutical company to surpass a trillion dollars in market value, joining a club largely dominated by technology giants. Since the start of 2023, its share price has more than tripled, with …

Vinay Lochav | 24 July 2026

Summit Therapeutics (NASDAQ: SMMT) Reports $690.7M in Cash Following Q2 Results

Summit Therapeutics Inc. (NASDAQ: SMMT) disclosed that its cash and investment holdings total $690.7 million at the close of the most recent quarter. This liquidity provides a solid foundation for the company’s ongoing oncology initiatives, including the development of its lead candidate, ivonescimab, which …

Vinay Lochav | 24 July 2026

Tenet Healthcare (NYSE: THC) Beats EPS, Raises FY 2026 EBITDA Outlook to $5.03 B

Tenet Healthcare reported adjusted diluted earnings of $6.12, up 52.2% year‑over‑year, and lifted its FY 2026 adjusted EBITDA outlook to a range of $4.83 billion‑$5.03 billion. The stronger earnings and higher guidance support the stock’s recent 10% monthly gain and suggest continued cash‑flow generation …

Vinay Lochav | 24 July 2026

Utah Medical Products (NASDAQ: UTMD) Posts 14.3% Q2 Revenue Drop After Losing Top Customers

Utah Medical Products posted 2Q 2026 revenue of $1.424 million, a 14.3% drop versus a year earlier, while 1H revenue fell 12.3% to $2.411 million. The decline, driven by loss of its two top customers, trims top‑line growth and pressures margins, signaling tighter earnings …

Vinay Lochav | 24 July 2026

Vaso Corp (OTC: VASO) Appoints Shaun McMeans to Board, Awards 100,000 Shares

Vaso Corp (OTC: VASO) named seasoned finance executive Shaun McMeans as a Class III director, immediately bestowing him a one‑time allotment of 100,000 common shares. McMeans, who currently steers finance at Nabsys and previously led the accounting function at HTG Molecular Diagnostics, will sit …

Vinay Lochav | 24 July 2026

NovoCure Revenue Hits Record High, Shares Surge 16% Post-Earnings

NovoCure Surpasses Forecasts With Record Q2 Revenue

Vinay Lochav | 24 July 2026

Oil Price Surge Pressures Wall Street, Lilly Ventures Into Obesity Treatment

Wall Street is experiencing downward pressure as rising oil prices impact investor sentiment and fuel concerns about inflation. Lilly's strategic shift towards developing a next-generation obesity drug could open new opportunities in the healthcare sector, presenting a contrasting narrative amid broader market volatility.Key HighlightsWall …

Vinay Lochav | 24 July 2026

Outbreak Expands to Four More States, Fine Day Index 102.3

The CDC added four states to the ongoing cyclosporiasis outbreak, noting a Fine Day index reading of 102.3. The expansion raises scrutiny on fresh‑produce supply chains, potentially tightening margins for grocery chains and increasing volatility in food‑service stocks.Key HighlightsFour new states are linked to …

Vinay Lochav | 24 July 2026

Leadership Changes at Outlook Therapeutics (NASDAQ: OTLK) Signal Strategic Focus

Outlook Therapeutics, Inc. (NASDAQ: OTLK) has granted a total of 310,078 stock options to its CEO and CFO, recognizing their contributions toward advancing the ONS-5010 application. With shares up 100% year-to-date, the stock performance highlights a responsive market environment as the FDA decision deadline …

Vinay Lochav | 24 July 2026
Support

Hi! How can we help you today?

Loading…